Latest PromarkerD clinical validation results published in the Journal of Diabetes and its...
Proteomics receives R&D tax incentive – AuManufacturing
“The company is commercialising its Promarker D predictive test for diabetic kidney disease. The government provides a cash rebate of 43.5 percent of expenditure on qualifying R&D activities.“
Article: MANUFACTURING NEWS BRIEFS – STORIES YOU MIGHT HAVE MISSED